Two Sigma Investments’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1
Closed -$3K 2850
2022
Q2
$3K Sell
1
-5
-83% -$15.5K ﹤0.01% 2441
2022
Q1
$22K Buy
+6
New +$40.8K ﹤0.01% 2526
2020
Q4
Sell
-4
Closed -$283K 3804
2020
Q3
$283K Buy
4
+3
+300% +$239K ﹤0.01% 2612
2020
Q2
$130K Buy
+1
New +$193K ﹤0.01% 2752

Other funds holding VTAK

Two Sigma Investments's VTAK Position: Q3 2022 in Review

Two Sigma Investments sold out of Catheter Precision (VTAK) in Q3 2022, closing a stake of 1 share — an estimated $3K sold.

Two Sigma Investments first reported a position in VTAK in Q2 2020 and held it in 4 quarters. The position peaked at $283K in Q3 2020. 17 funds tracked by Wall St. Rank hold VTAK as of Q3 2022.

  • Two Sigma Investments reported no remaining Catheter Precision position as of Q3 2022 after selling out during the quarter.
  • Two Sigma Investments sold 1 Catheter Precision share in Q3 2022, an estimated $3K.
  • Two Sigma Investments first reported a position in Catheter Precision in Q2 2020 and held it in 4 quarters.
  • Two Sigma Investments's Catheter Precision position peaked at $283K in Q3 2020.
  • 17 funds tracked by Wall St. Rank held Catheter Precision as of Q3 2022.

Based on Two Sigma Investments's 13F filing for Q3 2022, filed 14 Nov 2022.